Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
2021 · Nature · 292 citations
https://doi.org/10.1038/s41586-021-04246-z
J
Josh N. Vo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
3.1K
Citations
13
h-index
13
i10-index
Josh N. Vo is an academic researcher from University of Georgia. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Protein Degradation and Inhibitors & Antenna Design and Analysis. The author has an h-index of 13, co-authored 54 publications.
Papers by this author
worksThe genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma
2022 · Nature Communications · 84 citations
https://doi.org/10.1038/s41467-022-31430-0
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
2023 · Acta Neuropathologica · 31 citations
https://doi.org/10.1007/s00401-023-02640-7
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition
2024 · Cell Reports Medicine · 18 citations
https://doi.org/10.1016/j.xcrm.2024.101752
Next-Generation Sequencing–Based Molecular Profiling of Conjunctival Squamous Cell Carcinoma and Its Potential Application for Therapy
2025 · Ophthalmology Science · 2 citations
https://doi.org/10.1016/j.xops.2025.100801
Germline loss-of-function variant in the E3 ubiquitin ligase TRAF2 in a young adult patient with medulloblastoma: a case report
2024 · Acta Neuropathologica Communications · 0 citations
https://doi.org/10.1186/s40478-024-01896-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat